Castle Biosciences completes AltheaDx acquisition; issues 763,887 shares

CASTLE BIOSCIENCES INC

$65M initial consideration: $32.5M cash and $32.5M in stock (763,887 shares).
Up to $75M in milestone payments through Dec 31, 2024; 50% cash, 50% stock.
Max shares issuable capped at 1,271,718; up to 507,831 more for milestones.
Shares unregistered under Section 4(a)(2)/Reg D; resale registration due in 40 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.